Volume Overload and Hypotension in Pulmonary Hypertension

Pathophysiologic Mechanism

Excessive preload causes right ventricular overdistension, leading to decreased contractility and reduced stroke volume through the Frank-Starling mechanism's descending limb, as noted by the American College of Cardiology and Clinical Gastroenterology and Hepatology 1, 2
The net result is decreased systemic cardiac output manifesting as hypotension despite total body volume excess, according to the American College of Cardiology 1

Elevated jugular venous pressure (>10 cm H2O) with or without hepatojugular reflux is a reliable sign of volume overload, as indicated by the American Heart Association 3
Peripheral edema, ascites, or hepatomegaly indicates systemic congestion, as noted by the American Heart Association 3
Narrow pulse pressure, cool extremities, and altered mentation suggest low cardiac output, according to the American Heart Association 3
Elevated right atrial pressure (>14.5 mmHg pre-intervention or >21.5 mmHg post-intervention) is associated with increased mortality, as reported by Clinical Gastroenterology and Hepatology 2
Tricuspid regurgitation from right ventricular dysfunction and annular dilatation secondary to chronic volume overload is a common finding, as noted by the American College of Cardiology and Clinical Gastroenterology and Hepatology 1, 2

Initiate vasopressors and inotropes immediately rather than fluid administration to augment cardiac output and maintain perfusion, as recommended by the American College of Cardiology 4
Begin cautious diuresis even in the presence of hypotension, as reducing right ventricular preload improves function, according to the American College of Cardiology and the American Heart Association 5, 6
Target diuresis of 0.5-1.0 kg daily while monitoring for symptomatic hypotension, as suggested by the American Heart Association 6

Loop diuretics are first-line, with furosemide 20-40 mg IV (maximum 600 mg daily), bumetanide 0.5-1.0 mg IV (maximum 10 mg daily), or torsemide 10-20 mg IV (maximum 200 mg daily), as recommended by the American College of Cardiology 7
Torsemide may be preferred due to superior oral bioavailability and longer duration of action, as noted by the American Heart Association 6, 7

Vasopressor support is indicated for hypotension that does not resolve after appropriate volume management, as recommended by the American College of Cardiology 4
Inotropic agents (dobutamine, milrinone) may be beneficial for documented severe systolic dysfunction with low cardiac output, according to the American College of Cardiology 8

In the TIPS procedure context, volume overload is particularly dangerous in pulmonary hypertension patients, as TIPS acutely increases right atrial pressure by 3-5 mmHg and can precipitate cardiac decompensation, as noted by the American College of Cardiology and Clinical Gastroenterology and Hepatology 1, 2